The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Hypoxia-inducible factor 2α regulates macrophage function in mouse models of acute and tumor inflammation
Open accessAbstract
Hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha display unique and sometimes opposing activities in regulating cellular energy homeostasis, cell fate decisions, and oncogenesis. Macrophages exposed to hypoxia accumulate both HIF-1alpha and HIF-2alpha, and overexpression of HIF-2alpha in tumor-associated macrophages (TAMs) is specifically correlated with high-grade human tumors and poor prognosis. However, the precise role of HIF-2alpha during macrophage-mediated inflammatory responses remains unclear. To fully characterize cellular hypoxic adaptations, distinct functions of HIF-1alpha versus HIF-2alpha must be elucidated. We demonstrate here that mice lacking HIF-2alpha in myeloid cells (Hif2aDelta/Delta mice) are resistant to lipopolysaccharide-induced endotoxemia and display a marked inability to mount inflammatory responses to cutaneous and peritoneal irritants. Furthermore, HIF-2alpha directly regulated proinflammatory cytokine/chemokine expression in macrophages activated in vitro. Hif2aDelta/Delta mice displayed reduced TAM infiltration in independent murine hepatocellular and colitis-associated colon carcinoma models, and this was associated with reduced tumor cell proliferation and progression. Notably, HIF-2alpha modulated macrophage migration by regulating the expression of the cytokine receptor M-CSFR and the chemokine receptor CXCR4, without altering intracellular ATP levels. Collectively, our data identify HIF-2alpha as an important regulator of innate immunity, suggesting it may be a useful therapeutic target for treating inflammatory disorders and cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Myeloid-specific HIF-1α deletion results in defective glycolysis and ATP generation, leading to impairment of myeloid cell motility and function (Fig. 2B) [61,62].”
From Revisiting the HIF switch in the tumor and its immune microenvironment. (2022) · cites this paper as [62]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both HIF-1α or HIF-2α expression in TAMs have been associated with tumor progression and/or poor prognosis in multiple tumor types, whereas lack of HIF-1α or HIF-2α in TAMs decreases metastasis, cell proliferation, and expression of pro-inflammatory cytokines such as IL-6 [73–76].”
From The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation (2025) · cites this paper as [76]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both HIF-1α or HIF-2α expression in TAMs have been associated with tumor progression and/or poor prognosis in multiple tumor types, whereas lack of HIF-1α or HIF-2α in TAMs decreases metastasis, cell proliferation, and expression of pro-inflammatory cytokines such as IL-6 [73–76].”
From The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation (2025) · cites this paper as [76]
Experimental — accuracy not yet measuredIn the citing paper
“Indeed, TAM presence and number has been directly correlated with prognosis in a number of cancer types and model systems [42–44].”
From Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine (2012) · cites this paper as [42]
In the citing paper
“HIF2α is required for cytokine induction in macrophages (Imtiyaz et al., 2010).”
From Iron Regulatory Proteins Mediate Host Resistance to Salmonella Infection (2015) · cites this paper as Imtiyaz et al., 2010
In the citing paper
“Hif-2α is an important transcriptional regulator of hypoxic responses, controlling a variety of processes including hypoxic regulation of EPO synthesis [48, 49] and macrophage function [50, 51].”
From Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function (2013) · cites this paper as [51]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
Activators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1256 · Cited by 3,413
Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.
Kaelin, W. G., & Ratcliffe, P. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.009 · Cited by 3,251
Activators and Target Genes of Rel/NF-кB Transcription Factors
Loop, T., & Pahl, H. L. (2003) · Springer eBooks · doi:10.1007/978-94-010-0163-2_1 · Cited by 3,179
Lutz, M. B., Kukutsch, N. A., Ogilvie, A. L. J., Rößner, S., Koch, F., Romani, N., & Schuler, G. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(98)00204-x · Cited by 2,972
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
Akashi, K., Traver, D., Miyamoto, T., & Weissman, I. L. (2000) · Nature · doi:10.1038/35004599 · Cited by 2,617
Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
Tracey, K. J., Fong, Y., Hesse, D. G., Manogue, K. R., Lee, A. T., Kuo, G. C., Lowry, S. F., & Cerami, A. (1987) · Nature · doi:10.1038/330662a0 · Cited by 2,448
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
Research works printed but not linked: 2
- Raick, 1973, Cancer Res., 33, 269
- Leek, 2002, Cancer Res., 62, 1326
Cited by
Sorted by citations
Items 101–200 of 461
The therapeutic implications of immunosuppressive tumor aerobic glycolysis
Reinfeld, B. I., Rathmell, W. K., Kim, T. K., & Rathmell, J. C. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00727-3 · Cited by 135
Khaliq, A. M., Rajamohan, M., Saeed, O. A. M., Mansouri, K., Adil, A., Zhang, C., Turk, A. A., Carstens, J. L., House, M. G., Hayat, S., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01914-4 · Cited by 132
Joshi, S., Singh, A. R., Zulcic, M., & Durden, D. L. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0682 · Cited by 130
Fu, Z., Mowday, A. M., Smaill, J. B., Hermans, I. F., & Patterson, A. V. (2021) · Cells · doi:10.3390/cells10051006 · Cited by 133
The Thyroid Hormone Triiodothyronine Controls Macrophage Maturation and Functions
Perrotta, C., Buldorini, M., Assi, E., Cazzato, D., Palma, C. D., Clementi, E., & Cervia, D. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.10.006 · Cited by 135
Chemokines, cytokines and exosomes help tumors to shape inflammatory microenvironment
Атретханы, К.-С. Н., Drutskaya, M. S., Nedospasov, S. A., Grivennikov, S. I., & Kuprash, D. V. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.09.011 · Cited by 131
Intestinal hypoxia and hypoxia-induced signalling as therapeutic targets for IBD
Welden, S. V., Selfridge, A. C., & Hindryckx, P. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.101 · Cited by 128
HIF-2α is indispensable for regulatory T cell function
Hsu, T.-S., Lin, Y.-L., Wang, Y.-A., Mo, S.-T., Chi, P.-Y., Lai, A. C.-Y., Pan, H.-Y., Chang, Y.-J., & Lai, M.-Z. (2020) · Nature Communications · doi:10.1038/s41467-020-18731-y · Cited by 126
Hypoxia and Metabolic Factors That Influence Inflammatory Bowel Disease Pathogenesis
Glover, L. E., & Colgan, S. P. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.01.056 · Cited by 126
Hypoxic Signaling During Tissue Repair and Regenerative Medicine
Nauta, T. D., van Hinsbergh, V. W. M., & Koolwijk, P. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151119791 · Cited by 129
The irradiated tumor microenvironment: role of tumor-associated macrophages in vascular recovery
Russell, J. S., & Brown, J. M. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00157 · Cited by 122
Ahn, G., Seita, J., Hong, B.-J., Kim, Y.-E., Bok, S., Lee, C.-J., Kim, K. S., Lee, J. C., Leeper, N. J., Cooke, J. P., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320243111 · Cited by 117
Orchestration of Angiogenesis by Immune Cells
Bruno, A., Pagani, A., Pulze, L., Albini, A., Dallaglio, K., Noonan, D. M., & Mortara, L. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00131 · Cited by 117
Iron Regulatory Proteins Mediate Host Resistance to Salmonella Infection
Nairz, M., Ferring-Appel, D., Casarrubea, D., Sonnweber, T., Viatte, L., Schroll, A., Haschka, D., Fang, F. C., Hentze, M. W., Weiss, G., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.06.017 · Cited by 103
Influence of hypoxia-inducible factor 1α on dendritic cell differentiation and migration
Köhler, T., Reizis, B., Johnson, R. S., Weighardt, H., & Förster, I. (2012) · European Journal of Immunology · doi:10.1002/eji.201142053 · Cited by 108
Неганова, М. Е., Liu, J., Aleksandrova, Y. R., Klochkov, S. G., & Fan, R. (2021) · Cancers · doi:10.3390/cancers13236062 · Cited by 112
Laoui, D., Overmeire, E. V., Movahedi, K., den Bossche, J. V., Schouppe, E., Mommer, C., Nikolaou, A., Morias, Y., BAETSELIER, P. D., & Ginderachter, J. A. V. (2011) · Immunobiology · doi:10.1016/j.imbio.2011.06.007 · Cited by 104
Hypoxia in Solid Tumors: How Low Oxygenation Impacts the “Six Rs” of Radiotherapy
Rakotomalala, A., Escande, A., Furlan, A., Meignan, S., & Lartigau, E. F. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.742215 · Cited by 118
Ke, X., Chen, C., Song, Y., Cai, Q., Li, J., Tang, Y., Han, X., Qu, W., Chen, A., Wang, H., et al. (2019) · Oncology Letters · doi:10.3892/ol.2019.10956 · Cited by 105
Individualized precision treatment: Targeting TAM in HCC
Li, Z., Wu, T., Zheng, B. J., & Chen, L. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.05.019 · Cited by 101
Ribatti, D. (2013) · Immunology Letters · doi:10.1016/j.imlet.2013.05.003 · Cited by 99
Hypoxia-Induced Inflammation in the Lung
Fröhlich, S., Boylan, J. F., & McLoughlin, P. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0137tr · Cited by 100
Hypoxia/HIF Modulates Immune Responses
Chen, Y., & Gaber, T. (2021) · Biomedicines · doi:10.3390/biomedicines9030260 · Cited by 100
Immune Cells in Colorectal Cancer: Prognostic Relevance and Role of MSI
Deschoolmeester, V., Baay, M. F. D., Lardon, F., Pauwels, P., & Peeters, M. (2011) · Cancer Microenvironment · doi:10.1007/s12307-011-0068-5 · Cited by 99
Role of Intestinal HIF-2α in Health and Disease
Ramakrishnan, S. K., & Shah, Y. M. (2015) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105202 · Cited by 100
Paolini, L., Adam, C., Beauvillain, C., Preisser, L., Blanchard, S., Pignon, P., Seegers, V., Chevalier, L.-M., Campone, M., Wernert, R., et al. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0749 · Cited by 103
Origin and Functions of Tumor-Associated Myeloid Cells (TAMCs)
Sica, A., Porta, C., Morlacchi, S., Banfi, S., Strauss, L., Rimoldi, M., Totaro, M. G., & Riboldi, E. (2011) · Cancer Microenvironment · doi:10.1007/s12307-011-0091-6 · Cited by 96
HIF-mediated innate immune responses: cell signaling and therapeutic implications
Walmsley, S. R., Harris, A. J., Thompson, A. A. R., & Whyte, M. K. B. (2014) · Hypoxia · doi:10.2147/hp.s50269 · Cited by 93
Sami, E., Paul, B. T., Koziol, J. A., & ElShamy, W. M. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-2374 · Cited by 90
Hypoxia and HIF-1 activation in bacterial infections
Devraj, G., Beerlage, C., Brüne, B., & Kempf, V. A. J. (2016) · Microbes and Infection · doi:10.1016/j.micinf.2016.11.003 · Cited by 95
García-Martín, R., Alexaki, V. I., Qin, N., Rubín de Celis, M. F., Economopoulou, M., Ziogas, A., Gercken, B., Kotlabova, K., Phieler, J., Ehrhart-Bornstein, M., et al. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00430-15 · Cited by 86
Chamseddine, A. N., Assi, T., Mir, O., & Chouaïb, S. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107986 · Cited by 89
de Groot, J., Liang, J., Kong, L.-Y., Wei, J., Piao, Y., Fuller, G. N., Qiao, W., & Heimberger, A. B. (2012) · Oncotarget · doi:10.18632/oncotarget.663 · Cited by 86
Franke, K., Kalucka, J. M., Mamlouk, S., Singh, R. P., Muschter, A., Weidemann, A., Iyengar, V., Jahn, S., Wieczorek, K. S., Geiger, K. D., et al. (2012) · Blood · doi:10.1182/blood-2012-08-449181 · Cited by 86
Loss of the Oxygen Sensor PHD3 Enhances the Innate Immune Response to Abdominal Sepsis
Kiss, J., Mollenhauer, M., Walmsley, S. R., Kirchberg, J., Radhakrishnan, P., Niemietz, T., Dudda, J., Steinert, G., Whyte, M. K. B., Carmeliet, P., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103471 · Cited by 81
Islam, S. U., Lee, J., Shehzad, A., Ahn, E., Lee, Y. J., & Lee, Y. K. (2018) · Molecules · doi:10.3390/molecules23081880 · Cited by 84
Kim, Y.-E., Lee, M., Gu, H., Kim, J., Jeong, S., Yeo, S., Lee, Y. J., Im, S., Sung, Y., Kim, H. J., et al. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.033241 · Cited by 82
Immunometabolism and Sepsis: A Role for HIF?
Fitzpatrick, S. F. (2019) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00085 · Cited by 86
Davis, L., Recktenwald, M., Hutt, E., Fuller, S., Briggs, M., Goel, A., & Daringer, N. (2022) · Cancers · doi:10.3390/cancers14051259 · Cited by 83
Schouppe, E., BAETSELIER, P. D., Ginderachter, J. A. V., & Sarukhan, A. (2012) · OncoImmunology · doi:10.4161/onci.21566 · Cited by 83
Hypoxia and inflammatory bowel disease
Cummins, E. P., & Crean, D. (2016) · Microbes and Infection · doi:10.1016/j.micinf.2016.09.004 · Cited by 88
Sharma, A., Sinha, S., & Shrivastava, N. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.849040 · Cited by 85
De, A., De, A., Papasian, C. J., Hentges, S., Banerjee, S. K., Haque, I., & Banerjee, S. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072748 · Cited by 82
Gao, R. Y., Wang, M., Liu, Q., Feng, D., Wen, Y., Xia, Y., Colgan, S. P., Eltzschig, H. K., & Ju, C. (2019) · Hepatology · doi:10.1002/hep.30954 · Cited by 80
Systemic VHL gene functions and the VHL disease
Bader, H. L., & Hsu, T. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.04.032 · Cited by 81
Egners, A., Erdem, M., & Cramer, T. (2016) · Mediators of Inflammation · doi:10.1155/2016/2053646 · Cited by 79
Multi-omic signature of body weight change: results from a population-based cohort study
Wahl, S., Vogt, S., Stückler, F., Krumsiek, J., Bartel, J., Kacprowski, T., Schramm, K., Carstensen, M., Rathmann, W., Roden, M., et al. (2015) · BMC Medicine · doi:10.1186/s12916-015-0282-y · Cited by 77
Sadiku, P., & Walmsley, S. R. (2019) · EMBO Reports · doi:10.15252/embr.201847388 · Cited by 79
Roda, J. M., Sumner, L. A., Evans, R., Phillips, G. S., Marsh, C. B., & Eubank, T. D. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100841 · Cited by 74
Zhu, G., Tang, Y., Geng, N., Zheng, M. H., Jiang, J. D., Li, L., Li, K., Lei, Z., Chen, W., Fan, Y., et al. (2014) · Neoplasia · doi:10.1593/neo.132034 · Cited by 74
“Re-educating” Tumor Associated Macrophages as a Novel Immunotherapy Strategy for Neuroblastoma
Liu, K. X., & Joshi, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01947 · Cited by 74
Hypoxia-inducible factor plays a gut-injurious role in intestinal ischemia reperfusion injury
Kannan, K. B., Colorado, I., Reino, D. C., Palange, D., Lu, Q., Qin, X., Abungu, B., Watkins, A. C., Caputo, F. J., Xu, D.-Z., et al. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00459.2010 · Cited by 73
Regulation of skin inflammation and angiogenesis by EC-SOD via HIF-1α and NF-κB pathways
Kim, Y., Kim, B. H., Lee, H., Jeon, B., Lee, Y. S., Kwon, M.-J., & Kim, T. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.08.027 · Cited by 70
Shay, J. E. S., Imtiyaz, H. Z., Sivanand, S., Durham, A. C., Skuli, N., Hsu, S., Mucaj, V., Eisinger‐Mathason, T. S. K., Krock, B. L., Giannoukos, D. N., et al. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu004 · Cited by 73
Self-citationDeBerge, M., Lantz, C. W., Dehn, S., Sullivan, D. P., van der Laan, A. M., Niessen, H. W. M., Flanagan, M. E., Brat, D. J., Feinstein, M. J., Kaushal, S., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20200667 · Cited by 70
Macrophage HIF-2α suppresses NLRP3 inflammasome activation and alleviates insulin resistance
Li, X., Zhang, X., Xia, J., Zhang, L., Chen, B., Lian, G., Yun, C., Yang, J., Yan, Y., Wang, P., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109607 · Cited by 71
Regulation of Blood and Lymphatic Vessels by Immune Cells in Tumors and Metastasis
Mazzone, M., & Bergers, G. (2019) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020518-114721 · Cited by 70
Hypoxia as a Modulator of Inflammation and Immune Response in Cancer
Castillo‐Rodríguez, R. A., Trejo‐Solís, C., Cabrera‐Cano, A., Gómez‐Manzo, S., & Dávila‐Borja, V. M. (2022) · Cancers · doi:10.3390/cancers14092291 · Cited by 70
Influence of low oxygen tensions on macrophage polarization
Escribese, M. M., Casas, M., & Corbí, A. L. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.07.002 · Cited by 69
Macrophages in nonalcoholic fatty liver disease: a role model of pathogenic immunometabolism
Krenkel, O., & Tacke, F. (2017) · Seminars in Liver Disease · doi:10.1055/s-0037-1604480 · Cited by 66
Kiers, D., Wielockx, B., Peters, E., van Eijk, L. T., Gerretsen, J., John, A. T., Janssen, E., Groeneveld, R., Peters, M., Damen, L., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.06.021 · Cited by 68
The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation
Acuña-Pilarte, K., & Koh, M. Y. (2025) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2025.06.005 · Cited by 64
Zhang, J., Han, C., Dai, H., Hou, J., Dong, Y., Cui, X., Xu, L., Zhang, M., & Xia, Q. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014121248 · Cited by 64
Hypoxia-inducible factors as key regulators of tumor inflammation
Mamlouk, S., & Wielockx, B. (2013) · International Journal of Cancer · doi:10.1002/ijc.27901 · Cited by 61
Cardiac macrophages and emerging roles for their metabolism after myocardial infarction
Thorp, E. B. (2023) · Journal of Clinical Investigation · doi:10.1172/jci171953 · Cited by 66
Sun, Y., Pinto, C., Camus, S. M., Duval, V., Alayrac, P., Zlatanova, I., Loyer, X., Vilar, J., Lemitre, M., Levoye, A., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.11.051 · Cited by 63
Moreno Roig, E., Yaromina, A., Houben, R., Groot, A. J., Dubois, L., & Vooijs, M. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00224 · Cited by 60
The emerging role of hypoxia-inducible factor-2 involved in chemo/radioresistance in solid tumors
Zhao, J., Du, F., Luo, Y., Shen, G., Zheng, F., & Xu, B. (2015) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2015.05.004 · Cited by 59
Zhao, C., Mirando, A. C., Sové, R. J., Medeiros, T. X., Annex, B. H., & Popel, A. S. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007468 · Cited by 62
Danger matrix molecules orchestrate CD14/CD44 signaling in cancer development
Roedig, H., Damiescu, R., Zeng-Brouwers, J., Kutija, I., Trebicka, J., Wygrecka, M., & Schaefer, L. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.07.026 · Cited by 58
Hypoxia-inducible factor-2α plays a role in mediating oesophagitis in GORD
Huo, X., Agoston, A. T., Dunbar, K. B., Cipher, D. J., Zhang, X., Yu, C., Cheng, E., Zhang, Q., Pham, T. H., Tambar, U. K., et al. (2016) · Gut · doi:10.1136/gutjnl-2016-312595 · Cited by 60
Applying nanomedicine in maladaptive inflammation and angiogenesis
Alaarg, A., Pérez‐Medina, C., Metselaar, J. M., Nahrendorf, M., Fayad, Z. A., Storm, G., & Mulder, W. J. M. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.009 · Cited by 60
Atanasov, G., Dietel, C., Feldbrügge, L., Benzing, C., Krenzien, F., Brandl, A., Mann, E., Englisch, J. P., Schierle, K., Robson, S. C., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1331806 · Cited by 59
Mimouna, S., Gonçalvès, D., Barnich, N., Darfeuille–Michaud, A., Hofman, P. M., & Vouret‐Craviari, V. (2011) · Gut Microbes · doi:10.4161/gmic.18771 · Cited by 58
He, K., Chen, X., Han, C., Xu, L., Zhang, J., Zhang, M., & Xia, Q. (2013) · Kidney International · doi:10.1038/ki.2013.342 · Cited by 58
Tumor oxygenation and cancer therapy—then and now
Hughes, V. S., Wiggins, J. M., & Siemann, D. W. (2018) · British Journal of Radiology · doi:10.1259/bjr.20170955 · Cited by 63
Targeting PD-1 or PD-L1 in Metastatic Kidney Cancer: Combination Therapy in the First-Line Setting
Aggen, D. H., Drake, C. G., & Rini, B. I. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-3323 · Cited by 57
Hypoxia and hypoxia-inducible factors in myeloid cell-driven host defense and tissue homeostasis
Jantsch, J., & Schödel, J. (2015) · Immunobiology · doi:10.1016/j.imbio.2014.09.009 · Cited by 46
Hood, J. L. (2016) · Medical Hypotheses · doi:10.1016/j.mehy.2016.07.009 · Cited by 55
Wang, W., Li, X., Zheng, D., Zhang, D., Peng, X., Zhang, X., Ai, F., Wang, X., Ma, J., Xiong, W., et al. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.3018 · Cited by 55
Hypoxic Signalling in Tumour Stroma
Laitala, A., & Erler, J. T. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00189 · Cited by 55
The Ontogeny and Microenvironmental Regulation of Tumor-Associated Macrophages
Movahedi, K., & Ginderachter, J. A. V. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6704 · Cited by 53
Immunometabolism of pro-repair cells
Singer, B. D., & Chandel, N. S. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124613 · Cited by 53
Role of Bone Marrow-Derived Cells in Angiogenesis: Focus on Macrophages and Pericytes
Ding, Y., Song, N., & Luo, Y. (2012) · Cancer Microenvironment · doi:10.1007/s12307-012-0106-y · Cited by 52
Immunometabolism of Phagocytes and Relationships to Cardiac Repair
Zhang, S., Bories, G. F. P., Lantz, C. W., Emmons, R., Becker, A., Liu, E., Abecassis, M. M., Yvan‐Charvet, L., & Thorp, E. B. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00042 · Cited by 54
de Oliveira, J., Denadai, M. B., & Costa, D. L. (2022) · Antioxidants · doi:10.3390/antiox11050861 · Cited by 54
Liyanage, S. E., Fantin, A., Villacampa, P., Lange, C., Denti, L., Cristante, E., Smith, A. J., Ali, R. R., Luhmann, U. F. O., Bainbridge, J. W., et al. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.306681 · Cited by 49
Hypoxia-inducible factor-1α regulation of myeloid cells
Stothers, C. L., Luan, L., Fensterheim, B. A., & Bohannon, J. K. (2018) · Journal of Molecular Medicine · doi:10.1007/s00109-018-1710-1 · Cited by 52
Estrogen receptor determination and long term survival of patients with carcinoma of the breast.
Crowe, J. P., Gordon, N. H., Hubay, C. A., Shenk, R. R., Zollinger, R. M., Brumberg, D. J., Wl, M., & Shuck, J. M. (1991) · PubMed · Cited by 49
Hypoxia‐inducible factors in metabolic reprogramming during sepsis
Vanderhaeghen, T., Vandewalle, J., & Libert, C. (2020) · FEBS Journal · doi:10.1111/febs.15222 · Cited by 47
Chen, Z., Liu, X., Mei, Z., Wang, Z., & Xiao, W. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00718-13 · Cited by 48
Rao, P., & Suvas, S. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800422 · Cited by 48
The effects of radiation therapy on the macrophage response in cancer
Beach, C., MacLean, D., Majorova, D., Arnold, J. N., & Olcina, M. M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1020606 · Cited by 47
A Novel Network Profiling Analysis Reveals System Changes in Epithelial-Mesenchymal Transition
Shimamura, T., Imoto, S., Shimada, Y., Hosono, Y., Niida, A., Nagasaki, M., Yamaguchi, R., Takahashi, T., & Miyano, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020804 · Cited by 48
The potential role and trend of HIF‑1α in intervertebral disc degeneration: Friend or foe? (Review)
Li, Y., Liu, S., Pan, D., Xu, B., Xing, X., Zhou, H., Zhang, B., Zhou, S., Ning, G., & Feng, S. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.11878 · Cited by 45
Gan, E. S., & Ooi, E. E. (2020) · Virology Journal · doi:10.1186/s12985-020-01374-2 · Cited by 46
Macrophage–tumor crosstalk: role of TAMR tyrosine kinase receptors and of their ligands
Schmidt, T., Batalla, I. B., Schultze, A., & Loges, S. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0863-7 · Cited by 47
Snail1 Mediates Hypoxia-Induced Melanoma Progression
Liu, S., Kumar, S. M., Martin, J. S., Yang, R., & Xu, X. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.08.038 · Cited by 44
Role of the CXCL12–CXCR4 axis in the development of deep rectal endometriosis
Leconte, M., Chouzenoux, S., Nicco, C., Chéreau, C., Arkwright, S., Santulli, P., Weill, B. J., Chapron, C., Dousset, B. E., & Batteux, F. (2014) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2013.12.121 · Cited by 45
Winning, S., & Fandrey, J. (2016) · Journal of Immunology Research · doi:10.1155/2016/5134329 · Cited by 48
Metadata
- Authors
- Imtiyaz, H. Z., Williams, E. P., Hickey, M. M., Patel, S. A., Durham, A. C., Yuan, L.-J., Hammond, R., Gimotty, P. A., Keith, B., & Simon, M. C.
- Affiliations
- Howard Hughes Medical Institute (US)
- Abramson Cancer Center (US)
- Corresponding author
- Simon, M. Celeste
- Venue
- Journal of Clinical Investigation
- Published
- 2010-08-02
- Volume
- 120
- Issue
- 8
- Pages
- 2699-2714
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC2912179
- OpenAlex
- W2041418689
- Semantic Scholar
- f822a56ab9aa8dcad2e6f306df8394ee6666f231
- Cited by
- 461
- References
- 116
- Citations by year
- 2026: 17 · 2025: 23 · 2024: 22 · 2023: 26 · 2022: 38 · 2021: 45 · 2020: 33 · 2019: 27 · 2018: 29 · 2017: 18 · 2016: 32 · 2015: 23 · 2014: 36 · 2013: 29 · 2012: 32
- FWCI
- 12.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- Cancer Research Institute
- National Institutes of Health
- Directorate for Biological Sciences
- U.S. Public Health Service (66310)
- Abramson Family Cancer Research Institute
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Immunology and Microbiology › Immunology › Macrophage Migration Inhibitory Factor
- Keywords
- HIF-2α, HIF-1α, tumor-associated macrophages, macrophage function, hypoxia, innate immunity, endotoxemia, lipopolysaccharide, inflammatory cytokines, chemokines, macrophage migration, M-CSF receptor, CXCR4, hepatocellular carcinoma, tumor inflammation, myeloid-specific knockout
- MeSH terms
- Endothelial PAS Domain-Containing Protein 1, Acute Disease, Animals, Cell Movement, Disease Models, Animal, Female, Immunity, Innate, Inflammation, Lipopolysaccharides, Macrophages, Mice, Inbred C57BL, Neoplasms, Nitric Oxide, Cytokines, Endotoxemia, Receptors, CXCR4, Mice, Basic Helix-Loop-Helix Transcription Factors, Basic Helix-Loop-Helix Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
